Gluconeogenesis in Detail Flashcards
Define the key steps involved in the conversion of 3-carbon intermediates to 6-carbon intermediates in gluconeogenesis
pyruvate (PC)–> oxaloacetate (PEPCK)–> PEP
PEP –> intermediate –> G3P (DHAP)–> F16BP (F16BPase)-> F6P –> G6P (G6Pase) –> glucose
PC
pyruvate carboxylase
converts pyruvate to oxaloacetate (this is a anaplerotic reaction = can produce an intermediate from krebs)
pyruvate + bicarbonate (PC)–> oxaloacetate
pyruvate is 3C and adds a CO2 to form oxaloacetate which is 4C, in turn produces ATP (ADP–>ATP
PEPCK
PEPcarboxykinase
oxaloacetate loses CO2 (PEPCK) –> PEP
this reaction costs a GTP/ATP
*
PEP
Phosphoenolpyruvate (PEP)
DHAP
dihydroxyacetone phosphate (DHAP)
converts G3P to F16BP in gluconeogenesis
G3P
glyceraldehyde 3-phosphate
DHAP converts G3P –> F16BP in gluconeogenesis
and G3P –> intermediates down in glycolysis
F16BPase
Fructose-1,6-bisphosphatase
converts F16BP –> F6P in gluconeogenesis
like G6Pase, only found in liver
G6Pase
glucose-6-phosphotase
converts from G6P–> glucose
like F16BPase, only found in liver
describe the release of glucose from cytosolic glucose 6-phosphate
glycogen –> G6P in the liver
* transported by G6P transporter into ER lumen
(G6Pase)–> converted into glucose
* glucose exits out through GLUT-2 transporter into blood
The effects of the absence of the 2-OH group in glucose
2’OH is replaced by 18F (fluorine-18 isotope)
forms FdG (Fluorodeoxyglucose)
FdG can get trapped (phosphorylated by hexokinase) but can’t be further metabolised
* no longer can convert G6P –> F6P in glycolysis = glycolysis inhibited
use of 2-deoxy derivatives in clinical/cancer diagnostics
Use of FdG in cancer diagnosis
–> fluroescent but can’t be used up in glycolysis
fluorescent areas = high glucose oxidation occured/ using lots of glucose
cancer cells : wahlberg effect (glucose –> lactate)
using a lot more glucose than healthy cells
–> can be used to identify cancerous cells
Predict the flow of glycolysis and gluconeogenesis based on allosteric Regulators
ATP: inhibits glycolysis
ADP : activates glycolysis
AMP : activates glycolysis AND inhibits gluconeogenesis
citrate : inhibits glycolysis
F26BP overrides all and activates glycolysis AND inhibits gluconeogenesis
FBPase-2
converts F26BP –> F6P
activated by glucagon
and activates protein kinase (phosphorylation of PFK-2 deactivates it, converting it into FBPase 2)
PFK is inhibited and F16BPase activity increases
Decrease in [F26BP]
=> glycolysis inhibited
=> gluconeogenesis promoted
PFK-2
Phosphofructokinase-2
converts F6P –> F26BP
costs ATP (ATP –> ADP)
activated by insulin
–> activate phosphoproteinphosphotase
F26BP inhibits F16BPase as well as stimulating PFK
– So when F26BP is high, glycolysis is favoured
=> gluconeogenesis inhibited/ glycolysis activated
F26BP
Fructose 2,6-bisphosphate
key regulator to glycolysis
activates PFK-1 (F6P –> F16BP) / inhibits FBPase [reverse]
pfk